← All indications
Whooping Cough
A respiratory infection caused by BORDETELLA PERTUSSIS and characterized by paroxysmal coughing ending in a prolonged crowing intake of breath.
Drugs by status
Approved for this indication (4)
Phase 4 trials (19)
- montelukast
- bacille calmette-guerin
- diphtheria, tetanus and whole cell pertussis vaccine
- DTaP, inactivated poliovirus, haemophilus influenzae b conjugate, hepatitis b vaccine
- pneumococcal 13-valent conjugate vaccine
- quinvaxem
- acellular pertussis vaccine
- attenuated measles vaccine - Edmonston strain
- Tetanus and diphtheria toxoids adsorbed
- Diphtheria and Tetanus Toxoids and Acellular Pertussis Adsorbed and Inactivated Poliovirus Vaccine
- pertagen
- meningococcal (groups A, C, Y, W) tetanus toxoid conjugate vaccine
- haemophilus influenzae type b conjugate vaccine
- acellular pertussis vaccine (including diptheria and tetanus toxoids)
- bivalent oral polio vaccine (bopv), type 1 and type 3
- quadrivalent groups a, c, y, and w-135 meningococcal vaccine
- technetium tc-99m pentetate kit
- tetanus toxoid
- Inactivated polio virus - Enhanced
Phase 3 trials (13)
- 23-valent pneumococcal polysaccharide vaccine
- diphtheria-tetanus-whole cell pertussis-inactivated poliovirus-haemophilus influenzae b conjugate-hepatitis b vaccine
- human papillomavirus quadrivalent (types 6, 11, 16 and 18) vaccine, recombinant
- hepatitis b vaccine (recombinant)
- immune globulin (human)
- rotavirus vaccine, live, oral, pentavalent
- inactivated influenza vaccine
- live attenuated varicella vaccine
- pneumococcal 7-valent conjugate vaccine
- measles, mumps, rubella, varicella vaccine
- measles, mumps, and rubella vaccine
- diphtheria toxoid
- human rotavirus, live attenuated
Phase 2 trials (6)
Organizations
Organization Involved with Phase 4 Indications (43)
- Novo Nordisk
- Crucell
- Sanofi
- Sanofi-Aventis
- Novartis
- GlaxoSmithKline
- Institut Pasteur
- LG
- Shantha Biotechnics Limited
- deCODE genetics
- Bandim Health Project
- National Institutes of Health (NIH)
- National Institute of Allergy and Infectious Diseases (NIAID)
- Public Health England
- Swedish Institute for Infectious Disease Control
- Chulalongkorn University
- University of London
- Radboud University
- University of Southern Denmark
- University of Adelaide
- Dalhousie University
- Statens Serum Institut
- Tel Aviv University
- University of Turku
- Leiden University
- University of Oxford
- Max Planck Institute
- Medical Research Council, The Gambia
- Department of Health, United Kingdom
- European Commission
- +13 more
Organization Involved with Phase 3 Indications (7)
Organization Involved with Phase 2 Indications (12)
Organization Involved with Phase 1 Indications (6)
Organization Involved with Other Experimental Indications (5)